Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements

• Maria Teresa Esposito,
• Anna Hagström-Andersson,
• Ronald W. Stam,
• Stefania Bortoluzzi

Affiliations

Maria Teresa Esposito

School of Life and Health Science, University of Roehampton, London, United Kingdom

Anna Hagström-Andersson

Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden

Ronald W. Stam

Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands

Stefania Bortoluzzi

Department of Molecular Medicine, University of Padova, Padua, Italy